Credit Suisse to price 11.35% contingent coupon reverse convertible autocallables on Abiomed

New York, May 18 – Credit Suisse AG, London Branch plans to price 11.35% contingent coupon autocallable reverse convertible securities due May 23, 2019 linked to the common stock of Abiomed, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest is payable quarterly if the stock closes at or above the 70% coupon barrier level on the observation period for that quarter.

The notes will be automatically called at par if the stock closes at or above its initial share price on Nov. 20, 2018 or Feb. 21, 2019.

The payout at maturity will be par unless the shares close below the 70% knock-in level on any day during the life of the notes and finish below the initial level, in which case investors will receive a number of Abiomed shares equal to $1,000 divided by the initial share price or, at the issuer’s option, an amount in cash equal to the value of those shares.

Credit Suisse Securities (USA) LLC is the agent.

The notes will price on May 21 and settle on May 23.

The Cusip number is 22549JTJ9.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.